These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10676997)

  • 1. Sensitive determination of irinotecan (CPT-11) and its active metabolite SN-38 in human serum using liquid chromatography-electrospray mass spectrometry.
    Ragot S; Marquet P; Lachâtre F; Rousseau A; Lacassie E; Gaulier JM; Dupuy JL; Lachâtre G
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):175-84. PubMed ID: 10676997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatographic-tandem mass spectrometric assay for the simultaneous quantification of Camptosar and its metabolite SN-38 in mouse plasma and tissues.
    Bardin S; Guo W; Johnson JL; Khan S; Ahmad A; Duggan JX; Ayoub J; Ahmad I
    J Chromatogr A; 2005 May; 1073(1-2):249-55. PubMed ID: 15909526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection.
    de Bruijn P; Verweij J; Loos WJ; Nooter K; Stoter G; Sparreboom A
    J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):277-85. PubMed ID: 9367218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of irinotecan and its metabolite SN-38 in rabbit plasma and tumors using a validated method of tandem mass spectrometry coupled with liquid chromatography.
    Park DJ; Won JH; Cho AR; Yun HJ; Heo JH; Hwhang TH; Lee DH; Kim WM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():147-152. PubMed ID: 24927278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma.
    Rivory LP; Robert J
    J Chromatogr B Biomed Appl; 1994 Nov; 661(1):133-41. PubMed ID: 7866541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic assay with fluorescence detection for the simultaneous measurement of carboxylate and lactone forms of irinotecan and three metabolites in human plasma.
    Owens TS; Dodds H; Fricke K; Hanna SK; Crews KR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(1):65-74. PubMed ID: 12668072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trace analysis of SN-38 in human plasma by high-performance liquid chromatography.
    Rivory LP; Findlay M; Clarke S; Bishop J
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):355-9. PubMed ID: 9766876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic analysis of the anticancer drug irinotecan (CPT-11) and its active metabolite SN-38 in human plasma.
    Schoemaker NE; Rosing H; Jansen S; Schellens JH; Beijnen JH
    Ther Drug Monit; 2003 Feb; 25(1):120-4. PubMed ID: 12548157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study.
    Marangon E; Posocco B; Mazzega E; Toffoli G
    PLoS One; 2015; 10(2):e0118194. PubMed ID: 25689738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic determination of irinotecan (CPT-11) and its active metabolite (SN-38) in human plasma.
    Sumiyoshi H; Fujiwara Y; Ohune T; Yamaoka N; Tamura K; Yamakido M
    J Chromatogr B Biomed Appl; 1995 Aug; 670(2):309-16. PubMed ID: 8548021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
    Atasilp C; Chansriwong P; Sirachainan E; Reungwetwattana T; Puangpetch A; Prommas S; Sirilerttrakul S; Rerkarmnuaychoke B; Wongwaisayawan S; Sukasem C
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28393405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive and rapid liquid chromatography tandem mass spectrometry method for quantitative determination of 7-ethyl-10-hydroxycamptothecin (SN-38) in human plasma containing liposome-based SN-38 (LE-SN38).
    Khan S; Ahmad A; Ahmad I
    Biomed Chromatogr; 2003 Dec; 17(8):493-9. PubMed ID: 14648604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients.
    Barilero I; Gandia D; Armand JP; Mathieu-Boué A; Ré M; Gouyette A; Chabot GG
    J Chromatogr; 1992 Mar; 575(2):275-80. PubMed ID: 1629304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Femtomole quantitation of 7-ethyl-10-hydroxycamptothecine (SN-38) in plasma samples by reversed-phase high-performance liquid chromatography.
    de Bruijn P; de Jonge MJ; Verweij J; Loos WJ; Nooter K; Stoter G; Sparreboom A
    Anal Biochem; 1999 Apr; 269(1):174-8. PubMed ID: 10094790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of Irinotecan and its two major metabolites using a liquid chromatography-electrospray ionization tandem mass spectrometric.
    Zhang W; Dutschman GE; Li X; Ye M; Cheng YC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3038-44. PubMed ID: 19648066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: application to clinical pharmacokinetic studies.
    Escoriaza J; Aldaz A; Castellanos C; Calvo E; Giráldez J
    J Chromatogr B Biomed Sci Appl; 2000 Apr; 740(2):159-68. PubMed ID: 10821401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analytical method for irinotecan (CPT-11) and its metabolites using a high-performance liquid chromatography: parallel detection with fluorescence and mass spectrometry.
    Sai K; Kaniwa N; Ozawa S; Sawada J
    Biomed Chromatogr; 2002 May; 16(3):209-18. PubMed ID: 11920947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis.
    Gasthuys E; van Ovost J; Vande Casteele S; Cosyns S; Ceelen W; Van Bocxlaer J; Vermeulen A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123980. PubMed ID: 38215697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of liposomal irinotecan and SN-38 concentrations in plasma samples from children with solid tumors: Use of a cryoprotectant solution to enhance liposome stability.
    Nair S; Selvo NS; Stolarski A; Klee B; Federico SM; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Sep; 1245():124273. PubMed ID: 39146822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.
    Bansal T; Awasthi A; Jaggi M; Khar RK; Talegaonkar S
    Talanta; 2008 Sep; 76(5):1015-21. PubMed ID: 18761148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.